维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="DENMEADE SR"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A supramicromolar elevation of intracellular free calcium ( i) is consistently required to induce the execution phase of apoptosis 显示文摘	Tombal B Denmeade SR Gillis JM	2002	Cell death Differ2002，9，5：	1
2	Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer 显示文摘	Denmeade SR Lin XS Isaacs JT	1996	Prostate1996，28，4：	1
3	Development of prostate cancer treatment:a good news显示文摘	Denmeade SR Isaacs JT	2004	Prostate2004，58，3：	1
4	Dissociation between androgen responsiveness for malignant growth vs expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models显示文摘	Denmeade SR Sokoll LJ Dalrymple S	2003	Prostate2003，54，4：	1
5	Assessment and validation of a microinjection method for kinetic analysis of i in individual cells undergoing apoptosis显示文摘	Tombal B Denmeade SR Isaacs TJ	1999	Cell Calcium1999，25，1：	1
6	Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment显示文摘	Brennen WN Denmeade SR Isaacs JT	2013	Endocine-related Cancer2013，20，5：	1
7	Concentration of enzymatically active prostate-specific antigen( PSA ) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models显示文摘	Denmeade SR Sokoll LJ Chan DW	2001	Prostate2001，48，1：	1
8	Rationale behind targe- ting fibroblast activation protein-expressing ated fibroblasts as a novel chemotherapeutic strategy显示文摘	Brennen WN Isaacs JT Denmeade SR	2012	Mol Cancer Ther2012，11，2：	1
9	Rationale behind targe-ting fibroblast activation protein - expressing carcinoma - associat-ed fibroblasts as a novel chemotherapeutic strategy 显示文摘	Brennen WN Isaacs JT Denmeade SR	2012	Mol Canc-er Ther2012，11，2：	1
10	A 5-fluorodeoxyuridine prodrug as targeted therapy for prostate cancer 显示文摘	Mhaka A Denmeade SR Yao W	2002	Bioorg Med Chem Lett2002，12，17：	1
11	Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue显示文摘	Nelson JB Denmeade SR	1997	Clin Cancer Res1997，3，：	1
12	in vivo activity of PSA-activated doxorubicin prodrug against PSA-producing human prostate cancer xenografts显示文摘	Knan SR Denmeade SR	2000	The Prostate2000，45，1：	1
13	Prostate-specific antigenactivated thapsigargin prodrug as targeted therapy for prostate cancer显示文摘	Denmeade SR Jakobsen CM Janssen S		0，，：	1
14	Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy显示文摘	Brennen WN Isaacs JT Denmeade SR	2012	Mol Cancer Ther2012，11，2：	1
15	Role of programmed(apoptotic)cell death during the progression and therapy of prostate cancer显示文摘	Lin XS Isaacs JT	1996	Prostate1996，28，4：	1
16	A history of prostate cancer treatment显示文摘	DENMEADE SR ISAACS JT	2002	Nat Rev Cancer2002，2，5：	1
17	Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer显示文摘	Denmeade SR Lin XS Isaacs JT	1996	Prostate1996，28，4：	1
18	A history of prostate cancer treatment 显示文摘	Denmeade SR Isaacs JT	2002	Nat Rev Cancer2002，2，5：	1
19	Activation of latent protesse function of pro-hK2,but not pro-PSA,involves autoprocessing显示文摘	Denmeade SR Lovgren J Khan SR	2001	Prostate2001，48，2：	1
20	Rationale be- hind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemothera- peutic strategy显示文摘	Brennen WN Isaacs JT Denmeade SR	2012	Mol Cancer Ther2012，11，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示